Long-COVID symptoms persist for two years in over half of cases

23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.

Capsule sponge test revolutionizes GERD diagnosis, reduces unnecessary endoscopies

Capsule sponge testing, a minimally invasive diagnostic tool, effectively triages gastroesophageal reflux disease (GERD) patients, reducing unnecessary endoscopies by 70% and accurately identifying high-risk cases

December 2, 2024

First-Line Nivolumab Plus Chemo Approved for Bladder Cancer

The FDA approved the PD-1 immune checkpoint inhibitor nivolumab (Opdivo) in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or

March 8, 2024

FDA re-issues ban on electric shock devices

Dive Brief: Dive Insight: Human rights groups wrote to the FDA and the Department of Health and Human Services in January, asking it to release

March 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.